Activist Forager Capital to Withhold Votes for All Repay Holdings Directors
RPAY sits 58% above its 52-week low of $2.3 on light trading volume (0.3× avg).
Summary
Activist investor Forager Capital, the largest shareholder, announced it will withhold votes for all directors at the upcoming annual meeting, citing the Board's refusal to engage on a premium acquisition offer and poor stock performance.
Key Events · Ownership and Investor Activity · RPAY
-
Activist Vote Withholding
Forager Capital Management, a 12.4% owner, intends to withhold its vote from all directors standing for election at the Annual Meeting on June 10, 2026.
-
Criticism of Board Engagement
Forager criticized the Board for refusing substantive engagement on a 75% premium all-cash acquisition proposal and for governance paths that left stockholders without a meaningful voice.
-
Upcoming Annual Meeting Impact
This announcement directly impacts the upcoming Annual Meeting, intensifying the ongoing proxy battle between the company and its activist shareholders.
-
Ongoing Acquisition Interest
Forager reiterated its belief that a transaction involving the Issuer may be in the best interests of stockholders and remains willing to engage in discussions.
Analysis · RPAY · Trade & Services
Activist investor Forager Capital Management, holding a 12.4% stake, has escalated its proxy battle by announcing its intention to withhold votes for all directors at the upcoming Annual Meeting on June 10, 2026. This action follows previous criticisms of the Board's refusal to engage on a reported 75% premium all-cash acquisition proposal and the company's significant stock price decline over the past five years. This move puts direct pressure on the current board and could lead to significant changes in governance or strategy, especially with another activist investor, Veradace Capital Management, also engaged in a proxy fight.
At the time of this filing, RPAY was trading at $3.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $320.2M. The 52-week trading range was $2.30 to $6.06. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.